ICMR invites EoI to develop monoclonal antibodies against Nipah virus in India | Current Affairs | Vision IAS

Daily News Summary

Get concise and efficient summaries of key articles from prominent newspapers. Our daily news digest ensures quick reading and easy understanding, helping you stay informed about important events and developments without spending hours going through full articles. Perfect for focused and timely updates.

News Summary

Sun Mon Tue Wed Thu Fri Sat

    ICMR invites EoI to develop monoclonal antibodies against Nipah virus in India

    1 min read

    Development of Monoclonal Antibodies Against Nipah Virus in India

    Background and Importance

    • The Indian Council of Medical Research (ICMR) is seeking interest from organizations to develop monoclonal antibodies (mAbs) against the Nipah virus.
    • Nipah virus (NiV) is a significant zoonotic threat with outbreaks in India since 2001, exhibiting case fatality rates between 40% and 75%.
    • The Bangladesh clade (NiV-B) prevalent in India and Bangladesh is known for its high mortality and frequent human-to-human transmission.


    • Tags :
    • Nipah Virus
    Subscribe for Premium Features

    Quick Start

    Use our Quick Start guide to learn about everything this platform can do for you.
    Get Started